Switch to:
Onyx Pharmaceuticals, Inc. (NAS:ONXX)
Cash from Financing
$444.8 Mil (TTM As of Jun. 2013)

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Jun. 2013, Onyx Pharmaceuticals, Inc. received $25.8 Mil more from issuing new shares than it paid to buy back shares. It received $0.0 Mil from issuing more debt. It paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.0 Mil from paying cash dividends to shareholders. It received $0.0 Mil on other financial activities. In all, Onyx Pharmaceuticals, Inc. earned $25.8 Mil on financial activities for the three months ended in Jun. 2013.


Definition

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Onyx Pharmaceuticals, Inc.'s Cash from Financing for the fiscal year that ended in Dec. 2012 is calculated as:

Onyx Pharmaceuticals, Inc.'s Cash from Financing for the quarter that ended in Jun. 2013 is

Onyx Pharmaceuticals, Inc. Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2013 was 33.867 (Sep. 2012 ) + 21.782 (Dec. 2012 ) + 363.391 (Mar. 2013 ) + 25.785 (Jun. 2013 ) = $444.8 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

Cash from financing contains five items:

1. Net Issuance of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.

Onyx Pharmaceuticals, Inc.'s net issuance of stock for the three months ended in Jun. 2013 was $25.8 Mil. Onyx Pharmaceuticals, Inc. received $25.8 Mil more from issuing new shares than it paid to buy back shares.

2. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Onyx Pharmaceuticals, Inc.'s net issuance of debt for the three months ended in Jun. 2013 was $0.0 Mil. Onyx Pharmaceuticals, Inc. received $0.0 Mil from issuing more debt.

3. Net Issuance of Preferred:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Onyx Pharmaceuticals, Inc.'s net issuance of preferred for the three months ended in Jun. 2013 was $0.0 Mil. Onyx Pharmaceuticals, Inc. paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

4. Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Onyx Pharmaceuticals, Inc.'s cash flow for dividends for the three months ended in Jun. 2013 was $0.0 Mil. Onyx Pharmaceuticals, Inc. received $0.0 Mil from paying cash dividends to shareholders.

5. Other Financing:
Money spent or earned by company from other financial activities.

Onyx Pharmaceuticals, Inc.'s other financing for the three months ended in Jun. 2013 was $0.0 Mil. Onyx Pharmaceuticals, Inc. received $0.0 Mil on other financial activities.


Related Terms

Cash Flow from Operations, Cash Flow from Investing, Net Issuance of Stock, Net Issuance of Debt, Dividends, Net Issuance of Preferred


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Onyx Pharmaceuticals, Inc. Annual Data

Dec03Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12
Net Issuance of Stock 88.2152.3137.977.2227.525.1147.78.423.481.1
Net Issuance of Debt 0.00.00.00.0-0.80.0221.80.00.00.0
Net Issuance of Preferred 0.00.00.00.00.00.00.00.00.00.0
Dividends 0.00.00.00.00.00.00.00.00.00.0
Other Financing 15.00.010.010.0-0.0-22.5-23.90.00.00.0
Cash from Financing 103.2152.3147.987.2226.72.6345.78.423.481.1

Onyx Pharmaceuticals, Inc. Quarterly Data

Mar11Jun11Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13
Net Issuance of Stock 5.36.61.89.76.419.134.021.7363.425.8
Net Issuance of Debt 0.00.00.00.00.00.00.00.0-0.00.0
Net Issuance of Preferred 0.00.00.00.00.00.00.00.00.00.0
Dividends 0.00.00.00.00.00.00.00.00.00.0
Other Financing 0.0-0.20.00.20.00.0-0.10.10.00.0
Cash from Financing 5.36.41.89.96.419.133.921.8363.425.8
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide